In tumor cells, AKT signaling shows strong correlation with Tacstd2 expression [36] but MAPK/ERK, ErbB, TGFβ, Wnt/β-catenin, JAK/STAT, and integrin signaling have all been implicated as downstream targets of Tacstd2 [37]. The gene discussed is EGFR; the disease is neoplasm.